-
Revenue
$-57.39M
Net Income
-
Gross Margin
-
Op. Margin
$-88.32M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Operating Expenses | $59.10M | $59.10M | $83.89M | $103.70M | $161.25M | $125.70M |
| Research & Development | $26.88M | $26.88M | $46.18M | $54.81M | $113.32M | $90.62M |
| Operating Income | $-59.10M | $-59.10M | $-83.89M | $-103.70M | $-161.25M | $-125.70M |
| Interest Income | $1.40M | $1.40M | $3.53M | $5.15M | - | - |
| Other Income/Expense | $1.72M | $1.72M | $3.91M | $4.91M | $4.21M | $-48.32K |
| Net Income | $-57.39M | $-57.39M | $-79.98M | $-98.79M | $-157.04M | $-125.75M |
| Basic EPS | nan | -1.45 | -2.65 | -3.28 | -5.30 | -7.16 |
| Diluted EPS | nan | -1.45 | -2.65 | -3.28 | -5.30 | -7.16 |
| Basic Shares Outstanding | 7.2M | 39.5M | 30.2M | 30.1M | 29.6M | 17.6M |
| Diluted Shares Outstanding | 7.2M | 39.5M | 30.2M | 30.1M | 29.6M | 17.6M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.50M | $3.86M | $4.09M | $5.40M | $44.44M |
| Short-term Investments | $89.51M | $41.05M | $92.23M | $142.93M | $167.47M |
| Accounts Receivable | - | - | - | $512.43K | - |
| Total Current Assets | $93.98M | $45.80M | $97.51M | $152.87M | $223.30M |
| Other Non-current Assets | $19.50K | $21.98K | $43.12K | $34.88K | $28.29K |
| Total Assets | $94.00M | $45.82M | $97.55M | $152.91M | $223.33M |
| Accounts Payable | $1.57M | $4.13M | $3.51M | $5.26M | $11.19M |
| Accrued Liabilities | $4.86M | $6.16M | $8.69M | $7.21M | $3.87M |
| Total Current Liabilities | $6.43M | $10.29M | $12.19M | $12.47M | $15.06M |
| Total Liabilities | $7.49M | $10.30M | $12.19M | $12.47M | $15.06M |
| Common Stock | $73.33K | $30.17K | $30.10K | $30.10K | $27.74K |
| Retained Earnings | $-698.27M | $-640.88M | $-560.90M | $-462.11M | $-305.07M |
| Total Stockholders Equity | $86.51M | $35.52M | $85.36M | $140.44M | $208.26M |
| Total Liabilities & Equity | $94.00M | $45.82M | $97.55M | $152.91M | $223.33M |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $-57.39M | $-57.39M | $-79.98M | $-98.79M | $-157.04M | $-125.75M |
| Stock-based Compensation | $26.31M | $13.91M | $30.18M | $43.81M | $44.19M | $40.49M |
| Change in Receivables | - | - | - | - | $512.43K | - |
| Change in Payables | $-8.20M | $-2.56M | $624.55K | $-1.76M | $421.04K | $2.85M |
| Operating Cash Flow | $-88.32M | $-45.79M | $-51.76M | $-51.66M | $-103.80M | $-91.87M |
| Purchases of Investments | - | - | - | - | $47.29M | $222.98M |
| Investing Cash Flow | $-10.74M | $-48.14M | $51.56M | $50.45M | $19.73M | $-54.12M |
| Stock Issued | - | $93.64M | - | - | $42.73M | $184.64M |
| Financing Cash Flow | - | $93.56M | $-40.34K | $-98.46K | $45.02M | $187.94M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Operating Expenses | $10.33M | - | $38.77M | - |
| Research & Development | $4.04M | - | $18.81M | - |
| Operating Income | $-10.33M | - | $-38.77M | - |
| Interest Expense | - | - | - | - |
| Interest Income | $247.01K | - | $1.01M | - |
| Other Income/Expense | $235.85K | - | $1.25M | - |
| Net Income | $-10.09M | $-17.77M | $-37.52M | - |
| Basic EPS | -0.30 | - | -1.16 | - |
| Diluted EPS | -0.30 | - | -1.16 | - |
| Basic Shares Outstanding | $33.19M | - | $32.27M | - |
| Diluted Shares Outstanding | $33.19M | - | $32.27M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $1.38M | $3.86M |
| Short-term Investments | $12.50M | $41.05M |
| Total Current Assets | $14.85M | $45.80M |
| Other Non-current Assets | $21.98K | $21.98K |
| Total Assets | $14.88M | $45.82M |
| Accounts Payable | $1.45M | $4.13M |
| Accrued Liabilities | $3.74M | $6.16M |
| Total Current Liabilities | $5.19M | $10.29M |
| Total Liabilities | $5.41M | $10.30M |
| Common Stock | $33.19K | $30.17K |
| Retained Earnings | $-678.40M | $-640.88M |
| Total Stockholders Equity | $9.47M | $35.52M |
| Total Liabilities & Equity | $14.88M | $45.82M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-10.09M | $-17.77M | $-37.52M | - |
| Stock-based Compensation | - | - | $11.53M | - |
| Change in Payables | - | - | $-2.68M | - |
| Operating Cash Flow | - | - | $-31.19M | - |
| Investing Cash Flow | - | - | $28.79M | - |
| Financing Cash Flow | - | - | $-73.02K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.